Neurone-specific enolase (NSE) and CD56 may also be positive, but they are not as sensitive and specific as the former two.[1] The 2003 World Health Organization classification of breast cancers stated that neuroendocrine markers being more than 50% were adequate for diagnosis. This evidence concerns the gene ENO2 and breast carcinoma.